Search Results

What the Doctor Didn't Order.

• Authors : Hongoltz-Hetling, Matthew

Subjects: PUBLIC health; PHARMACEUTICAL industry; NATIONAL health services

• Source: New Republic. Mar2023, Vol. 254 Issue 3, p20-29. 10p. 1 Color Photograph, 1 Illustration.

Record details

Opioids, Addiction, and Drug Companies: Overview.

• Authors : Ho, J. D.

Subjects: OPIOID abuse; DRUG abuse; DRUG overdoseUNITED StatesUNITED StatesUNITED StatesReport Available

• Source: Points of View: Opioids, Addiction & Drug Companies. 5/31/2022, p1-4. 4p. 1 Color Photograph.

Record details

Vaccine Hesitancy, Pharmaceutical Marketing, and Mistrusted Messengers.

• Authors : Colgrove, James (AUTHOR)

Subjects: SAFETY; HEALTH policy; SERIAL publications

• Source: American Journal of Public Health. Feb2024, Vol. 114 Issue 2, p155-157. 3p.

Record details

MarketLine Industry Profile: Pharmaceuticals in United States.

Subjects: *PHARMACEUTICAL industryUNITED StatesJOHNSON & Johnson (Company) JOHNSON & Johnson (Company) JOHNSON & Johnson (Company) JNJ; PFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE; ASTRAZENECA PLC ASTRAZENECA PLC ASTRAZENECA PLC AZN

• Source: Pharmaceuticals Industry Profile: United States. Feb2023, p1-50. 50p.

Record details

Pros and Cons of Importing Prescription Drugs: Reduced costs vs. safety and shortage factors.

Subjects: DRUG approval; DRUG prices; BIPARTISANSHIPUNITED StatesUNITED StatesUNITED StatesReport Available

• Source: Congressional Digest. Mar2024, Vol. 103 Issue 3, p27-27. 1p.

Record details

Dementia, a Polypharmaceutical Phenomenon: The Intimate Combinations of Dementia Drugs in Brazil.

• Authors : Engel, Cíntia

Subjects: PHARMACEUTICAL industry; DEMENTIA; COMORBIDITY

• Source: Culture, Medicine & Psychiatry. Sep2023, Vol. 47 Issue 3, p814-833. 20p.

Record details

NOT-FOR-PROFIT DRUGS.

• Authors : JAROS, JOHN

Subjects: *PHARMACEUTICAL industry; ANTIFUNGAL agents

• Source: Scientific American. Oct2021, Vol. 325 Issue 4, p6-9. 2p.

Record details

China's $220 Billion Biotech Flub.

• Authors : Einhorn, Bruce; Dong Lyu

Subjects: *PHARMACEUTICAL industry; *BIOTECHNOLOGY industries; *TECHNOLOGICAL innovationsCHINA

• Source: Bloomberg Businessweek. 5/22/2023, Issue 4784, p10-12. 3p. 3 Color Photographs, 1 Black and White Photograph, 1 Graph.

Record details

The Curious Tale of Hydroxychloroquine.

• Authors : Clancy, Robert¹

Subjects: Pharmaceutical industry; Drug prices; Pharmaceutical reference pricing

• Source: Quadrant Magazine. Mar2024, Vol. 68 Issue 3, p21-24. 4p.

Record details

Ann Arbor drugmaker settles suit against European distributor.

• Authors : Walsh, Dustin (AUTHOR)

Subjects: *PHARMACEUTICAL industry; *BUSINESSPEOPLEANN Arbor (Mich.)EUROPEAN Economic Area ; DAIICHI Sankyo Inc.

• Source: Crain's Detroit Business. 1/8/2024, Vol. 40 Issue 1, p7-7. 1p.

Record details